摘要
背景:骨质疏松症是全世界最常见的骨骼疾病。类黄酮具有减轻骨质疏松症患者骨骼改变的潜力,其优点是比传统疗法更安全、更便宜。 目的:主要目的是分析不同类黄酮类化合物在骨骼中触发的分子机制。此外,本综述还对骨质疏松性骨骼与健康骨骼的细胞和分子方面进行了最新概述,并简要描述了一些流行病学研究,表明类黄酮可能对骨质疏松症治疗有用。 方法:检索PubMed数据库,使用关键词骨质疏松症,类黄酮及其亚类,如黄酮,黄酮醇,黄烷醇,黄烷醇,异黄酮,黄烷酮和花青素,将数据集中在骨骼中触发的分子机制上。 结果:尽管类黄酮包含许多结构不同的化合物,但它们对绝经后妇女或卵巢切除诱导的骨质疏松动物的骨质流失的影响非常相似。它们中的大多数增加骨矿物质密度和骨强度,这是通过增强成骨细胞生成和破骨细胞凋亡,骨细胞生成减少以及骨质疏松性骨折部位新生血管形成增加来实现的。 结论:几种信号通路分子参与类黄酮对骨质疏松性骨的影响。是否所有类黄酮都有共同的机制,或者它们作为雌激素受体的配体仍有待确定。需要更多的临床试验来更好地了解它们在人体中的安全性,有效性,递送和生物利用度,以及与传统疗法的比较研究。
关键词: 骨质疏松性骨,黄酮,黄酮醇,黄烷醇,异黄酮,黄烷酮,花青素。
Current Medicinal Chemistry
Title:Analysis of the Molecular Mechanisms by Flavonoids with Potential Use for Osteoporosis Prevention or Therapy
Volume: 29 Issue: 16
关键词: 骨质疏松性骨,黄酮,黄酮醇,黄烷醇,异黄酮,黄烷酮,花青素。
摘要:
Background: Osteoporosis is the most common skeletal disorder worldwide. Flavonoids have the potential to alleviate bone alterations in osteoporotic patients with the advantage of being safer and less expensive than conventional therapies.
Objective: The main objective is to analyze the molecular mechanisms triggered in bone by different subclasses of flavonoids. In addition, this review provides an up-to-date overview of the cellular and molecular aspects of osteoporotic bones versus healthy bones, and a brief description of some epidemiological studies indicating that flavonoids could be useful for osteoporosis treatment.
Methods: The PubMed database was searched in 2001- 2021 using the keywords osteoporosis, flavonoids, and their subclasses such as flavones, flavonols, flavanols, isoflavones, flavanones and anthocyanins, focusing the data on the molecular mechanisms triggered in bone.
Results: Although flavonoids comprise many compounds that differ in structure, their effects on bone loss in postmenopausal women or in ovariectomized-induced osteoporotic animals are quite similar. Most of them increase bone mineral density and bone strength, which occur through an enhancement of osteoblastogenesis and osteoclast apoptosis, a decrease in osteoclastogenesis, as well as an increase in neovascularization on the site of the osteoporotic fracture.
Conclusion: Several molecules of signaling pathways are involved in the effect of flavonoids on osteoporotic bone. Whether all flavonoids have a common mechanism or they act as ligands of estrogen receptors remains to be established. More clinical trials are necessary to know better their safety, efficacy, delivery and bioavailability in humans, as well as comparative studies with conventional therapies.
Export Options
About this article
Cite this article as:
Analysis of the Molecular Mechanisms by Flavonoids with Potential Use for Osteoporosis Prevention or Therapy, Current Medicinal Chemistry 2022; 29 (16) . https://dx.doi.org/10.2174/0929867328666210921143644
DOI https://dx.doi.org/10.2174/0929867328666210921143644 |
Print ISSN 0929-8673 |
Publisher Name Bentham Science Publisher |
Online ISSN 1875-533X |
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
- Announcements